40 results
Page 2 of 2
8-K
EX-99.1
g87ejnbgtr8a0i7qk7r5
4 Oct 21
Departure of Directors or Certain Officers
4:06pm
S-3ASR
5oscbxlw
16 Aug 21
Automatic shelf registration
5:19pm
8-K
EX-99.1
e86yxrydtd9k djtnx
16 Aug 21
Annexon Biosciences Reports Second Quarter 2021 Financial Results and Provides Mid-Year Business Update
4:11pm
8-K
EX-99.1
qulie
17 May 21
Annexon Biosciences Provides Business Update and Reports First Quarter 2021 Financial Results
4:17pm
DEF 14A
9a03pahjuk81jj1
22 Apr 21
Definitive proxy
4:06pm
8-K
EX-99.1
28g3fn g6y
25 Mar 21
Annexon Biosciences Reports Fourth Quarter and Full-Year 2020 Financial Results
7:20am
10-K
3eviq32so9 j9u29
25 Mar 21
Annual report
7:16am
8-K
EX-99.1
vv8sk 1ep
11 Jan 21
Regulation FD Disclosure
6:06am
10-Q
4grrb7h
8 Sep 20
Quarterly report
5:18pm
424B4
z03 wfoo070lsemn27c
24 Jul 20
Prospectus supplement with pricing info
5:15pm
S-1/A
1k5m1b5jg5bd 66w7wl
20 Jul 20
IPO registration (amended)
6:07am
S-1
9zv899twtqv
2 Jul 20
IPO registration
12:00am
DRS/A
9zhkv97qbtv64ij
26 Feb 20
Draft registration statement (amended)
12:00am
DRS/A
lr6wb17r
6 Dec 19
Draft registration statement (amended)
12:00am
DRS/A
53d0lsjfphqeqg xxt
8 Nov 19
Draft registration statement (amended)
12:00am
DRS
oh0ho523
18 Sep 19
Draft registration statement
12:00am